These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 9846181

  • 1. Differential apoptotic response of human melanoma cells to 1 alpha,25-dihydroxyvitamin D3 and its analogues.
    Danielsson C, Fehsel K, Polly P, Carlberg C.
    Cell Death Differ; 1998 Nov; 5(11):946-52. PubMed ID: 9846181
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A.
    Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699
    [Abstract] [Full Text] [Related]

  • 3. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.
    Quack M, Clarin A, Binderup E, Björkling F, Hansen CM, Carlberg C.
    J Cell Biochem; 1998 Dec 01; 71(3):340-50. PubMed ID: 9831071
    [Abstract] [Full Text] [Related]

  • 4. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
    Seifert M, Rech M, Meineke V, Tilgen W, Reichrath J.
    J Steroid Biochem Mol Biol; 2004 May 01; 89-90(1-5):375-9. PubMed ID: 15225804
    [Abstract] [Full Text] [Related]

  • 5. Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity.
    Danielsson C, Mathiasen IS, James SY, Nayeri S, Bretting C, Hansen CM, Colston KW, Carlberg C.
    J Cell Biochem; 1997 Sep 15; 66(4):552-62. PubMed ID: 9282333
    [Abstract] [Full Text] [Related]

  • 6. Metabolism of the vitamin D3 analogue EB1089 alters receptor complex formation and reduces promoter selectivity.
    Quack M, Mørk Hansen C, Binderup E, Kissmeyer AM, Carlberg C.
    Br J Pharmacol; 1998 Oct 15; 125(4):607-14. PubMed ID: 9831892
    [Abstract] [Full Text] [Related]

  • 7. The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity.
    Nayeri S, Danielsson C, Kahlen JP, Schräder M, Mathiasen IS, Binderup L, Carlberg C.
    Oncogene; 1995 Nov 02; 11(9):1853-8. PubMed ID: 7478614
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
    Golovko O, Nazarova N, Tuohimaa P.
    Life Sci; 2005 Jun 17; 77(5):562-77. PubMed ID: 15904673
    [Abstract] [Full Text] [Related]

  • 9. Positive and negative interaction of 1,25-dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis.
    Danielsson C, Törmä H, Vahlquist A, Carlberg C.
    Int J Cancer; 1999 May 05; 81(3):467-70. PubMed ID: 10209963
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines.
    Evans SR, Houghton AM, Schumaker L, Brenner RV, Buras RR, Davoodi F, Nauta RJ, Shabahang M.
    J Surg Res; 1996 Feb 15; 61(1):127-33. PubMed ID: 8769954
    [Abstract] [Full Text] [Related]

  • 11. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
    Yang L, Yang J, Venkateswarlu S, Ko T, Brattain MG.
    J Cell Physiol; 2001 Sep 15; 188(3):383-93. PubMed ID: 11473365
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro.
    James SY, Mercer E, Brady M, Binderup L, Colston KW.
    Br J Pharmacol; 1998 Nov 15; 125(5):953-62. PubMed ID: 9846632
    [Abstract] [Full Text] [Related]

  • 15. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
    Mathiasen IS, Lademann U, Jäättelä M.
    Cancer Res; 1999 Oct 01; 59(19):4848-56. PubMed ID: 10519395
    [Abstract] [Full Text] [Related]

  • 16. 1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro.
    Heine G, Anton K, Henz BM, Worm M.
    Eur J Immunol; 2002 Dec 01; 32(12):3395-404. PubMed ID: 12432570
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 01; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.